Allison Lindstrom
Primary Care · Chicago, ILNPI 1619457728
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by QOL Medical, LLC at 51.6% of the total. Reporting peaked in 2024 at $9,903 and has fallen 99.7% since, to $27 in 2025. Among primary care clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 386 payments — averaging $37.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- QOL Medical, LLC$8K
- AbbVie$2K
- Johnson & Johnson$1K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$967
- Bristol Myers Squibb$372
- plus $2K from 22 others
What the payments were for
- Speaking & faculty fees$6,25043%
- Travel & lodging$4023%
- Food & beverage$7,74053%
- Education$2071%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| QOL Medical, LLC | 45 | $7,527 |
| AbbVie | 86 | $1,634 |
| Johnson & Johnson | 31 | $1,147 |
| Takeda Pharmaceuticals U.S.A., Inc. | 64 | $1,143 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 50 | $967 |
| Bristol Myers Squibb | 23 | $372 |
| Ardelyx, Inc. | 15 | $349 |
| Pfizer | 10 | $219 |
| Ironwood Pharmaceuticals, Inc | 13 | $213 |
| Regeneron Healthcare Solutions, Inc. | 6 | $176 |
| Braintree Laboratories, Inc. | 9 | $161 |
| Lilly USA, LLC | 6 | $139 |
| Phathom Pharmaceuticals, Inc. | 5 | $90 |
| Currax Pharmaceuticals LLC | 5 | $70 |
| Intercept Pharmaceuticals, Inc. | 3 | $62 |
| Celltrion USA Inc. | 2 | $40 |
| Ferring Pharmaceuticals Inc. | 2 | $40 |
| Fresenius Kabi USA, LLC | 1 | $29 |
| Merck | 1 | $29 |
| Sandoz | 1 | $28 |
| Ipsen Biopharmaceuticals, Inc | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Evoke Pharma, Inc. | 1 | $23 |
| Mirum Pharmaceuticals, Inc. | 1 | $22 |
| Gilead | 1 | $20 |
| Vibrant Gastro, Inc. | 1 | $19 |
| Vivus LLC | 1 | $17 |
| Exact Sciences | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,599 in reported general payments places this provider in the 95th percentile of 150 primary care providers in Illinois.
Other primary care in Chicago
- Dawn ConwayChicago$11K
- Ashley CarterChicago$7K
- Jennifer VazquezChicago$5K
- Lauren CiminoChicago$4K
- Yasmin FayazChicago$3K
- Bridget FlanaganChicago$3K
- Ecaterina ZamfirChicago$2K
- Elena IgnatievChicago$2K
- Reem ZayadChicago$2K
- Sarah MasseyChicago$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.